MobiHealth News March 28, 2025
The terms align with the company’s brain-computer interface technologies aimed at restoring vision and enabling mind-controlled device use.
Elon Musk’s brain-computer interface (BCI) implant startup Neuralink has filed applications with the United States Patent and Trademark Office (USPTO) to trademark the terms “Telepathy,” “Blindsight,” and “Telekinesis.”
The applications, filed in early March, pertain to Neuralink’s first product, Telepathy, a brain-computer interface that aims to allow users to control devices with their thoughts; Blindsight, an implant that aims to restore vision in individuals who are blind; and Telekinesis, a term Musk has used interchangeably with Telepathy relating to controlling devices using one’s mind.
Neuralink’s PRIME study (short for Precise Robotically Implanted Brain-Computer Interface) involves the placement of a small,...
Today's Sponsors
Today's Sponsor